5-Ht2b Receptor Antagonists
Compounds of formulae: (I), (II), (IIIa), (IIIb), (IVa) and (IVb): or a pharmaceutically acceptable salt thereof, for use as pharmaceuticals, in particular for the treatment of a condition alleviated by antagonism of a 5-HT2B receptor.
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | CLARK KENNETH LYLE HARRIS NEIL VICTOR ALEY AMANDA ARCHER JANET ANN COLEMAN ROBERT ALEXANDER BORMAN RICHARD ANTHONY OXFORD ALEXANDER WILLIAM HYND GEORGE |
| description | Compounds of formulae: (I), (II), (IIIa), (IIIb), (IVa) and (IVb): or a pharmaceutically acceptable salt thereof, for use as pharmaceuticals, in particular for the treatment of a condition alleviated by antagonism of a 5-HT2B receptor. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2009018150A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2009018150A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2009018150A13</originalsourceid><addsrcrecordid>eNrjZJA21fUoMUpSCEpNTi0oyS9ScMwrSUzPz8ssLinmYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxocFGBgaWBoYWhqYGjobGxKkCALZDI6s</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>5-Ht2b Receptor Antagonists</title><source>esp@cenet</source><creator>CLARK KENNETH LYLE ; HARRIS NEIL VICTOR ; ALEY AMANDA ; ARCHER JANET ANN ; COLEMAN ROBERT ALEXANDER ; BORMAN RICHARD ANTHONY ; OXFORD ALEXANDER WILLIAM ; HYND GEORGE</creator><creatorcontrib>CLARK KENNETH LYLE ; HARRIS NEIL VICTOR ; ALEY AMANDA ; ARCHER JANET ANN ; COLEMAN ROBERT ALEXANDER ; BORMAN RICHARD ANTHONY ; OXFORD ALEXANDER WILLIAM ; HYND GEORGE</creatorcontrib><description>Compounds of formulae: (I), (II), (IIIa), (IIIb), (IVa) and (IVb): or a pharmaceutically acceptable salt thereof, for use as pharmaceuticals, in particular for the treatment of a condition alleviated by antagonism of a 5-HT2B receptor.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2009</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090115&DB=EPODOC&CC=US&NR=2009018150A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090115&DB=EPODOC&CC=US&NR=2009018150A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CLARK KENNETH LYLE</creatorcontrib><creatorcontrib>HARRIS NEIL VICTOR</creatorcontrib><creatorcontrib>ALEY AMANDA</creatorcontrib><creatorcontrib>ARCHER JANET ANN</creatorcontrib><creatorcontrib>COLEMAN ROBERT ALEXANDER</creatorcontrib><creatorcontrib>BORMAN RICHARD ANTHONY</creatorcontrib><creatorcontrib>OXFORD ALEXANDER WILLIAM</creatorcontrib><creatorcontrib>HYND GEORGE</creatorcontrib><title>5-Ht2b Receptor Antagonists</title><description>Compounds of formulae: (I), (II), (IIIa), (IIIb), (IVa) and (IVb): or a pharmaceutically acceptable salt thereof, for use as pharmaceuticals, in particular for the treatment of a condition alleviated by antagonism of a 5-HT2B receptor.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2009</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJA21fUoMUpSCEpNTi0oyS9ScMwrSUzPz8ssLinmYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxocFGBgaWBoYWhqYGjobGxKkCALZDI6s</recordid><startdate>20090115</startdate><enddate>20090115</enddate><creator>CLARK KENNETH LYLE</creator><creator>HARRIS NEIL VICTOR</creator><creator>ALEY AMANDA</creator><creator>ARCHER JANET ANN</creator><creator>COLEMAN ROBERT ALEXANDER</creator><creator>BORMAN RICHARD ANTHONY</creator><creator>OXFORD ALEXANDER WILLIAM</creator><creator>HYND GEORGE</creator><scope>EVB</scope></search><sort><creationdate>20090115</creationdate><title>5-Ht2b Receptor Antagonists</title><author>CLARK KENNETH LYLE ; HARRIS NEIL VICTOR ; ALEY AMANDA ; ARCHER JANET ANN ; COLEMAN ROBERT ALEXANDER ; BORMAN RICHARD ANTHONY ; OXFORD ALEXANDER WILLIAM ; HYND GEORGE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2009018150A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2009</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>CLARK KENNETH LYLE</creatorcontrib><creatorcontrib>HARRIS NEIL VICTOR</creatorcontrib><creatorcontrib>ALEY AMANDA</creatorcontrib><creatorcontrib>ARCHER JANET ANN</creatorcontrib><creatorcontrib>COLEMAN ROBERT ALEXANDER</creatorcontrib><creatorcontrib>BORMAN RICHARD ANTHONY</creatorcontrib><creatorcontrib>OXFORD ALEXANDER WILLIAM</creatorcontrib><creatorcontrib>HYND GEORGE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CLARK KENNETH LYLE</au><au>HARRIS NEIL VICTOR</au><au>ALEY AMANDA</au><au>ARCHER JANET ANN</au><au>COLEMAN ROBERT ALEXANDER</au><au>BORMAN RICHARD ANTHONY</au><au>OXFORD ALEXANDER WILLIAM</au><au>HYND GEORGE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>5-Ht2b Receptor Antagonists</title><date>2009-01-15</date><risdate>2009</risdate><abstract>Compounds of formulae: (I), (II), (IIIa), (IIIb), (IVa) and (IVb): or a pharmaceutically acceptable salt thereof, for use as pharmaceuticals, in particular for the treatment of a condition alleviated by antagonism of a 5-HT2B receptor.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US2009018150A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | 5-Ht2b Receptor Antagonists |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T04%3A46%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CLARK%20KENNETH%20LYLE&rft.date=2009-01-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2009018150A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |